SCHEMBL8647902

SCHEMBL8647902

COC(=O)C1Cc2ccccc2N1c1ncnc2cc(OC)c(OC)cc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.55
CSF1R P07333 1/20 0.54
PDGFRB P09619 4/20 0.50
ACHE P22303 4/20 0.50
BACE1 P56817 4/20 0.50
RET P07949 2/20 0.47
KIF5B P33176 1/20 0.47
KDR P35968 1/20 0.47
HTR1A P08908 2/20 0.47
HTR7 P34969 2/20 0.47
PDE10A Q9Y233 1/20 0.47
KIT P10721 3/20 0.46
MAPK1 P28482 1/20 0.46
ENPP1 P22413 1/20 0.46
FGFR1 P11362 1/20 0.46
PDGFRA P16234 1/20 0.46
FGFR2 P21802 1/20 0.46
FGFR4 P22455 1/20 0.46
FGFR3 P22607 1/20 0.46
FLT3 P36888 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium SCHEMBL8650904 0.90 EGFR (0.55) EGFRCSF1RPDGFRBACHEBACE1
Lithium Ion SCHEMBL8650898 0.90 EGFR (0.55) EGFRCSF1RPDGFRBACHEBACE1
SCHEMBL8650896 0.90 EGFR (0.55) EGFRCSF1RPDGFRBACHEBACE1
SCHEMBL8647403 0.83 EGFR (0.61) EGFRCSF1RACHEBACE1RET
SCHEMBL27477800 0.82 EGFR (0.60) EGFRCSF1RACHEBACE1RET
SCHEMBL9113385 0.81 EGFR (0.57) EGFRCSF1RACHEBACE1RET
SCHEMBL4718427 0.77 EGFR (0.65) EGFRCSF1RACHEBACE1RET
Hydrochloric Acid SCHEMBL6181670 0.76 EGFR (0.66) EGFRCSF1RACHEBACE1RET
SCHEMBL5468434 0.71 ACHE (0.68) EGFRCSF1RACHEBACE1HTR7
SCHEMBL6185124 0.71 EGFR (1.00) EGFRCSF1RACHEBACE1RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5736534-A HYPERPROLIFERATIVE DISEASES; INHIBITORS OF PROTEIN-TYROSINE KINASES SUCH AS EPIDERMAL GROWTH FACTOR RECEPTOR; BRAIN, LUNG, BREAST CANCER; PSORIASIS AND BENIGN PROSTATE HYPERPLASIA PFIZER INC. (US) 1998-04-07 US disclosed
CN-1141633-A 4-heterocyclic substituted quinazoline derivatives, process for their preparation and their use as anticancer agents PFIZER (US) 1997-01-29 CN disclosed
EP-0746554-A1 4-HETEROCYCLYL-SUBSTITUTED QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS ANTI-CANCER AGENTS PFIZER INC. (US) 1996-12-11 EP disclosed
WO-1995023141-A1 4-HETEROCYCLYL-SUBSTITUTED QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS ANTI-CANCER AGENTS PFIZER INC. (US) 1995-08-31 WO disclosed